Alissia Opitz

Recent experience includes advising:

• Proalpha Group on its acquisition of Insiders Technologies GmbH.
• Stellex Capital Management LLC on the acquisition financing of Dürr’s environmental technology business.
• Permira and its portfolio company Neuraxpharm on Neuraxpharm’s successful €925 million term loan B refinancing.
• ADVANZ PHARMA, a Nordic Capital portfolio company, in connection with the issuance of €917 million (equivalent) in new euro- and pound sterling-denominated senior secured notes and the borrowing of a €165 million term loan B facility.
• Kartesia in connection with the financing of the management buy-out of the German consultancy firm goetzpartners (now Fortlane Partners).
• Rivean Capital on the acquisition of Perbility GmbH.
• Siris Capital Group in its US$591 Million sale of Fiery.
• Marlin Equity Partners on the acquisition of a majority stake in Treasury Intelligence Solutions GmbH.
• One Equity Partners and Buckthorn Partners on the financing of the acquisition of Acteon Group.
• Deutsche Bank on the financing of the acquisition of Suter Group by Heizkurier Group, a portfolio company of NORD Holding.
• Rivean Capital on the acquisition of Green Mobility Holding GmbH.

• Member of the Munich Bar Association (Rechtsanwaltskammer München).
• Member of the German-American Lawyers’ Association (Deutsch-Amerikanische Juristen-Vereinigung e.V. (DAJV)).
• Member of the German-French Lawyers’ Association (Deutsch-Französische Juristenvereinigung e.V. (DFJ)).